nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—PTGS1—kidney cancer	0.378	1	CbGaD
Montelukast—SLCO2B1—Erlotinib—kidney cancer	0.114	0.279	CbGbCtD
Montelukast—CYP3A4—Everolimus—kidney cancer	0.0398	0.0977	CbGbCtD
Montelukast—CYP2C8—Pazopanib—kidney cancer	0.0348	0.0855	CbGbCtD
Montelukast—CYP3A4—Temsirolimus—kidney cancer	0.0269	0.066	CbGbCtD
Montelukast—CYP2C9—Capecitabine—kidney cancer	0.0253	0.0622	CbGbCtD
Montelukast—CYP2C8—Erlotinib—kidney cancer	0.0249	0.061	CbGbCtD
Montelukast—CYP2C8—Paclitaxel—kidney cancer	0.0228	0.0558	CbGbCtD
Montelukast—CYP2C8—Sorafenib—kidney cancer	0.0202	0.0496	CbGbCtD
Montelukast—CYP2C9—Paclitaxel—kidney cancer	0.0159	0.0389	CbGbCtD
Montelukast—CYP3A4—Pazopanib—kidney cancer	0.0141	0.0347	CbGbCtD
Montelukast—CYP2C9—Sorafenib—kidney cancer	0.0141	0.0346	CbGbCtD
Montelukast—CYP3A4—Erlotinib—kidney cancer	0.0101	0.0247	CbGbCtD
Montelukast—CYP3A4—Paclitaxel—kidney cancer	0.00923	0.0226	CbGbCtD
Montelukast—CYP3A4—Sorafenib—kidney cancer	0.0082	0.0201	CbGbCtD
Montelukast—CYP3A4—Vinblastine—kidney cancer	0.00809	0.0199	CbGbCtD
Montelukast—CYP3A4—Vincristine—kidney cancer	0.00796	0.0195	CbGbCtD
Montelukast—CYP3A4—Sunitinib—kidney cancer	0.00664	0.0163	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—kidney cancer	0.00497	0.0122	CbGbCtD
Montelukast—Gastrointestinal pain—Sunitinib—kidney cancer	0.000164	0.000913	CcSEcCtD
Montelukast—Hepatobiliary disease—Capecitabine—kidney cancer	0.000164	0.000913	CcSEcCtD
Montelukast—Pruritus—Erlotinib—kidney cancer	0.000164	0.000913	CcSEcCtD
Montelukast—Fatigue—Dactinomycin—kidney cancer	0.000163	0.000911	CcSEcCtD
Montelukast—Epistaxis—Capecitabine—kidney cancer	0.000163	0.00091	CcSEcCtD
Montelukast—Pain—Dactinomycin—kidney cancer	0.000162	0.000904	CcSEcCtD
Montelukast—Eczema—Doxorubicin—kidney cancer	0.000161	0.000898	CcSEcCtD
Montelukast—Anaphylactic shock—Gemcitabine—kidney cancer	0.000161	0.000896	CcSEcCtD
Montelukast—Oedema—Gemcitabine—kidney cancer	0.000161	0.000896	CcSEcCtD
Montelukast—Infection—Gemcitabine—kidney cancer	0.000159	0.00089	CcSEcCtD
Montelukast—Dizziness—Vinblastine—kidney cancer	0.000159	0.000887	CcSEcCtD
Montelukast—Dizziness—Everolimus—kidney cancer	0.000158	0.000884	CcSEcCtD
Montelukast—Muscle spasms—Paclitaxel—kidney cancer	0.000158	0.000884	CcSEcCtD
Montelukast—Abdominal pain—Sunitinib—kidney cancer	0.000158	0.000883	CcSEcCtD
Montelukast—Body temperature increased—Sunitinib—kidney cancer	0.000158	0.000883	CcSEcCtD
Montelukast—Diarrhoea—Erlotinib—kidney cancer	0.000158	0.000883	CcSEcCtD
Montelukast—Nervous system disorder—Gemcitabine—kidney cancer	0.000157	0.000879	CcSEcCtD
Montelukast—Thrombocytopenia—Gemcitabine—kidney cancer	0.000157	0.000877	CcSEcCtD
Montelukast—Skin disorder—Gemcitabine—kidney cancer	0.000156	0.00087	CcSEcCtD
Montelukast—Rhinitis—Capecitabine—kidney cancer	0.000156	0.000869	CcSEcCtD
Montelukast—Hepatitis—Capecitabine—kidney cancer	0.000155	0.000867	CcSEcCtD
Montelukast—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000155	0.000864	CcSEcCtD
Montelukast—Hypoaesthesia—Capecitabine—kidney cancer	0.000154	0.000862	CcSEcCtD
Montelukast—Tremor—Paclitaxel—kidney cancer	0.000154	0.000861	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000154	0.00086	CcSEcCtD
Montelukast—Pharyngitis—Capecitabine—kidney cancer	0.000154	0.00086	CcSEcCtD
Montelukast—Urinary tract disorder—Capecitabine—kidney cancer	0.000153	0.000856	CcSEcCtD
Montelukast—Hypersensitivity—Sorafenib—kidney cancer	0.000153	0.000855	CcSEcCtD
Montelukast—Insomnia—Vincristine—kidney cancer	0.000153	0.000854	CcSEcCtD
Montelukast—Vomiting—Vinblastine—kidney cancer	0.000153	0.000853	CcSEcCtD
Montelukast—Dizziness—Erlotinib—kidney cancer	0.000153	0.000853	CcSEcCtD
Montelukast—Connective tissue disorder—Capecitabine—kidney cancer	0.000153	0.000851	CcSEcCtD
Montelukast—Vomiting—Everolimus—kidney cancer	0.000152	0.00085	CcSEcCtD
Montelukast—Urethral disorder—Capecitabine—kidney cancer	0.000152	0.000849	CcSEcCtD
Montelukast—Paraesthesia—Vincristine—kidney cancer	0.000152	0.000848	CcSEcCtD
Montelukast—Agitation—Paclitaxel—kidney cancer	0.000151	0.000845	CcSEcCtD
Montelukast—Rash—Everolimus—kidney cancer	0.000151	0.000843	CcSEcCtD
Montelukast—Dermatitis—Everolimus—kidney cancer	0.000151	0.000842	CcSEcCtD
Montelukast—Headache—Vinblastine—kidney cancer	0.000151	0.000841	CcSEcCtD
Montelukast—Angioedema—Paclitaxel—kidney cancer	0.00015	0.00084	CcSEcCtD
Montelukast—Headache—Everolimus—kidney cancer	0.00015	0.000838	CcSEcCtD
Montelukast—Body temperature increased—Dactinomycin—kidney cancer	0.00015	0.000836	CcSEcCtD
Montelukast—Abdominal pain—Dactinomycin—kidney cancer	0.00015	0.000836	CcSEcCtD
Montelukast—Asthenia—Sorafenib—kidney cancer	0.000149	0.000833	CcSEcCtD
Montelukast—Hypersensitivity—Sunitinib—kidney cancer	0.000147	0.000823	CcSEcCtD
Montelukast—Pruritus—Sorafenib—kidney cancer	0.000147	0.000821	CcSEcCtD
Montelukast—Vomiting—Erlotinib—kidney cancer	0.000147	0.00082	CcSEcCtD
Montelukast—Erythema multiforme—Capecitabine—kidney cancer	0.000147	0.000819	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000146	0.000816	CcSEcCtD
Montelukast—Gastrointestinal disorder—Vincristine—kidney cancer	0.000146	0.000815	CcSEcCtD
Montelukast—Fatigue—Vincristine—kidney cancer	0.000146	0.000814	CcSEcCtD
Montelukast—Rash—Erlotinib—kidney cancer	0.000146	0.000813	CcSEcCtD
Montelukast—Dermatitis—Erlotinib—kidney cancer	0.000146	0.000813	CcSEcCtD
Montelukast—Palpitations—Paclitaxel—kidney cancer	0.000146	0.000812	CcSEcCtD
Montelukast—Insomnia—Gemcitabine—kidney cancer	0.000145	0.00081	CcSEcCtD
Montelukast—Headache—Erlotinib—kidney cancer	0.000145	0.000808	CcSEcCtD
Montelukast—Pain—Vincristine—kidney cancer	0.000145	0.000808	CcSEcCtD
Montelukast—Paraesthesia—Gemcitabine—kidney cancer	0.000144	0.000805	CcSEcCtD
Montelukast—Cardiac disorder—Capecitabine—kidney cancer	0.000144	0.000804	CcSEcCtD
Montelukast—Cough—Paclitaxel—kidney cancer	0.000144	0.000802	CcSEcCtD
Montelukast—Asthenia—Sunitinib—kidney cancer	0.000144	0.000801	CcSEcCtD
Montelukast—Nausea—Vinblastine—kidney cancer	0.000143	0.000797	CcSEcCtD
Montelukast—Somnolence—Gemcitabine—kidney cancer	0.000143	0.000797	CcSEcCtD
Montelukast—Convulsion—Paclitaxel—kidney cancer	0.000143	0.000796	CcSEcCtD
Montelukast—Nausea—Everolimus—kidney cancer	0.000142	0.000794	CcSEcCtD
Montelukast—Diarrhoea—Sorafenib—kidney cancer	0.000142	0.000794	CcSEcCtD
Montelukast—Pruritus—Sunitinib—kidney cancer	0.000142	0.00079	CcSEcCtD
Montelukast—Immune system disorder—Capecitabine—kidney cancer	0.00014	0.000783	CcSEcCtD
Montelukast—Arthralgia—Paclitaxel—kidney cancer	0.00014	0.000783	CcSEcCtD
Montelukast—Myalgia—Paclitaxel—kidney cancer	0.00014	0.000783	CcSEcCtD
Montelukast—Mediastinal disorder—Capecitabine—kidney cancer	0.00014	0.000781	CcSEcCtD
Montelukast—Anxiety—Paclitaxel—kidney cancer	0.00014	0.00078	CcSEcCtD
Montelukast—Hypersensitivity—Dactinomycin—kidney cancer	0.00014	0.000779	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000139	0.000777	CcSEcCtD
Montelukast—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000139	0.000774	CcSEcCtD
Montelukast—Fatigue—Gemcitabine—kidney cancer	0.000138	0.000772	CcSEcCtD
Montelukast—Gastrointestinal pain—Vincristine—kidney cancer	0.000138	0.000772	CcSEcCtD
Montelukast—Dizziness—Sorafenib—kidney cancer	0.000137	0.000767	CcSEcCtD
Montelukast—Pain—Gemcitabine—kidney cancer	0.000137	0.000766	CcSEcCtD
Montelukast—Nausea—Erlotinib—kidney cancer	0.000137	0.000766	CcSEcCtD
Montelukast—Diarrhoea—Sunitinib—kidney cancer	0.000137	0.000764	CcSEcCtD
Montelukast—Mental disorder—Capecitabine—kidney cancer	0.000136	0.000759	CcSEcCtD
Montelukast—Asthenia—Dactinomycin—kidney cancer	0.000136	0.000758	CcSEcCtD
Montelukast—Anaphylactic shock—Paclitaxel—kidney cancer	0.000134	0.00075	CcSEcCtD
Montelukast—Oedema—Paclitaxel—kidney cancer	0.000134	0.00075	CcSEcCtD
Montelukast—Body temperature increased—Vincristine—kidney cancer	0.000134	0.000747	CcSEcCtD
Montelukast—Abdominal pain—Vincristine—kidney cancer	0.000134	0.000747	CcSEcCtD
Montelukast—Infection—Paclitaxel—kidney cancer	0.000134	0.000745	CcSEcCtD
Montelukast—Dizziness—Sunitinib—kidney cancer	0.000132	0.000738	CcSEcCtD
Montelukast—Vomiting—Sorafenib—kidney cancer	0.000132	0.000738	CcSEcCtD
Montelukast—Nervous system disorder—Paclitaxel—kidney cancer	0.000132	0.000736	CcSEcCtD
Montelukast—Thrombocytopenia—Paclitaxel—kidney cancer	0.000132	0.000734	CcSEcCtD
Montelukast—Rash—Sorafenib—kidney cancer	0.000131	0.000732	CcSEcCtD
Montelukast—Dermatitis—Sorafenib—kidney cancer	0.000131	0.000731	CcSEcCtD
Montelukast—Skin disorder—Paclitaxel—kidney cancer	0.000131	0.000729	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00013	0.000727	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00013	0.000727	CcSEcCtD
Montelukast—Headache—Sorafenib—kidney cancer	0.00013	0.000727	CcSEcCtD
Montelukast—Muscle spasms—Capecitabine—kidney cancer	0.00013	0.000725	CcSEcCtD
Montelukast—Diarrhoea—Dactinomycin—kidney cancer	0.00013	0.000723	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—kidney cancer	0.000129	0.000722	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000128	0.000712	CcSEcCtD
Montelukast—Vomiting—Sunitinib—kidney cancer	0.000127	0.00071	CcSEcCtD
Montelukast—Body temperature increased—Gemcitabine—kidney cancer	0.000127	0.000708	CcSEcCtD
Montelukast—Tremor—Capecitabine—kidney cancer	0.000127	0.000707	CcSEcCtD
Montelukast—Rash—Sunitinib—kidney cancer	0.000126	0.000704	CcSEcCtD
Montelukast—Dermatitis—Sunitinib—kidney cancer	0.000126	0.000703	CcSEcCtD
Montelukast—Headache—Sunitinib—kidney cancer	0.000125	0.0007	CcSEcCtD
Montelukast—Asthma—Doxorubicin—kidney cancer	0.000125	0.000698	CcSEcCtD
Montelukast—Influenza—Doxorubicin—kidney cancer	0.000125	0.000698	CcSEcCtD
Montelukast—Hypersensitivity—Vincristine—kidney cancer	0.000125	0.000696	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—kidney cancer	0.000124	0.000691	CcSEcCtD
Montelukast—Nausea—Sorafenib—kidney cancer	0.000124	0.000689	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—kidney cancer	0.000123	0.000684	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000122	0.000683	CcSEcCtD
Montelukast—Insomnia—Paclitaxel—kidney cancer	0.000122	0.000678	CcSEcCtD
Montelukast—Asthenia—Vincristine—kidney cancer	0.000121	0.000678	CcSEcCtD
Montelukast—Paraesthesia—Paclitaxel—kidney cancer	0.000121	0.000674	CcSEcCtD
Montelukast—Vomiting—Dactinomycin—kidney cancer	0.00012	0.000672	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—kidney cancer	0.00012	0.000671	CcSEcCtD
Montelukast—Somnolence—Paclitaxel—kidney cancer	0.000119	0.000667	CcSEcCtD
Montelukast—Palpitations—Capecitabine—kidney cancer	0.000119	0.000667	CcSEcCtD
Montelukast—Rash—Dactinomycin—kidney cancer	0.000119	0.000667	CcSEcCtD
Montelukast—Nausea—Sunitinib—kidney cancer	0.000119	0.000663	CcSEcCtD
Montelukast—Dyspepsia—Paclitaxel—kidney cancer	0.000118	0.00066	CcSEcCtD
Montelukast—Cough—Capecitabine—kidney cancer	0.000118	0.000658	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000116	0.000649	CcSEcCtD
Montelukast—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000116	0.000648	CcSEcCtD
Montelukast—Fatigue—Paclitaxel—kidney cancer	0.000116	0.000647	CcSEcCtD
Montelukast—Diarrhoea—Vincristine—kidney cancer	0.000116	0.000646	CcSEcCtD
Montelukast—Asthenia—Gemcitabine—kidney cancer	0.000115	0.000643	CcSEcCtD
Montelukast—Myalgia—Capecitabine—kidney cancer	0.000115	0.000642	CcSEcCtD
Montelukast—Arthralgia—Capecitabine—kidney cancer	0.000115	0.000642	CcSEcCtD
Montelukast—Pain—Paclitaxel—kidney cancer	0.000115	0.000641	CcSEcCtD
Montelukast—Anxiety—Capecitabine—kidney cancer	0.000115	0.00064	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000114	0.000638	CcSEcCtD
Montelukast—Pruritus—Gemcitabine—kidney cancer	0.000114	0.000634	CcSEcCtD
Montelukast—Nausea—Dactinomycin—kidney cancer	0.000113	0.000628	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—kidney cancer	0.000112	0.000626	CcSEcCtD
Montelukast—Dizziness—Vincristine—kidney cancer	0.000112	0.000625	CcSEcCtD
Montelukast—Infestation—Doxorubicin—kidney cancer	0.000111	0.000622	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—kidney cancer	0.000111	0.000622	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—kidney cancer	0.000111	0.000622	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000111	0.000617	CcSEcCtD
Montelukast—Oedema—Capecitabine—kidney cancer	0.00011	0.000616	CcSEcCtD
Montelukast—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00011	0.000613	CcSEcCtD
Montelukast—Diarrhoea—Gemcitabine—kidney cancer	0.00011	0.000613	CcSEcCtD
Montelukast—Infection—Capecitabine—kidney cancer	0.00011	0.000612	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000109	0.00061	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—kidney cancer	0.000109	0.000606	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—kidney cancer	0.000108	0.000605	CcSEcCtD
Montelukast—Nervous system disorder—Capecitabine—kidney cancer	0.000108	0.000604	CcSEcCtD
Montelukast—Thrombocytopenia—Capecitabine—kidney cancer	0.000108	0.000603	CcSEcCtD
Montelukast—Vomiting—Vincristine—kidney cancer	0.000108	0.000601	CcSEcCtD
Montelukast—Skin disorder—Capecitabine—kidney cancer	0.000107	0.000598	CcSEcCtD
Montelukast—Urticaria—Paclitaxel—kidney cancer	0.000107	0.000596	CcSEcCtD
Montelukast—Rash—Vincristine—kidney cancer	0.000107	0.000596	CcSEcCtD
Montelukast—Dermatitis—Vincristine—kidney cancer	0.000107	0.000595	CcSEcCtD
Montelukast—Body temperature increased—Paclitaxel—kidney cancer	0.000106	0.000593	CcSEcCtD
Montelukast—Abdominal pain—Paclitaxel—kidney cancer	0.000106	0.000593	CcSEcCtD
Montelukast—Headache—Vincristine—kidney cancer	0.000106	0.000592	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000105	0.000588	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—kidney cancer	0.000105	0.000587	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—kidney cancer	0.000105	0.000584	CcSEcCtD
Montelukast—Vomiting—Gemcitabine—kidney cancer	0.000102	0.00057	CcSEcCtD
Montelukast—Rash—Gemcitabine—kidney cancer	0.000101	0.000565	CcSEcCtD
Montelukast—Dermatitis—Gemcitabine—kidney cancer	0.000101	0.000564	CcSEcCtD
Montelukast—Headache—Gemcitabine—kidney cancer	0.000101	0.000561	CcSEcCtD
Montelukast—Nausea—Vincristine—kidney cancer	0.000101	0.000561	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.0001	0.000561	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—kidney cancer	0.0001	0.00056	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—kidney cancer	0.0001	0.000559	CcSEcCtD
Montelukast—Insomnia—Capecitabine—kidney cancer	9.98e-05	0.000557	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—kidney cancer	9.96e-05	0.000556	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—kidney cancer	9.93e-05	0.000554	CcSEcCtD
Montelukast—Paraesthesia—Capecitabine—kidney cancer	9.9e-05	0.000553	CcSEcCtD
Montelukast—Hypersensitivity—Paclitaxel—kidney cancer	9.9e-05	0.000553	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—kidney cancer	9.88e-05	0.000552	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—kidney cancer	9.83e-05	0.000549	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—kidney cancer	9.81e-05	0.000548	CcSEcCtD
Montelukast—Dyspepsia—Capecitabine—kidney cancer	9.71e-05	0.000542	CcSEcCtD
Montelukast—Asthenia—Paclitaxel—kidney cancer	9.64e-05	0.000538	CcSEcCtD
Montelukast—Nausea—Gemcitabine—kidney cancer	9.54e-05	0.000532	CcSEcCtD
Montelukast—Gastrointestinal disorder—Capecitabine—kidney cancer	9.52e-05	0.000531	CcSEcCtD
Montelukast—Fatigue—Capecitabine—kidney cancer	9.51e-05	0.000531	CcSEcCtD
Montelukast—Pruritus—Paclitaxel—kidney cancer	9.51e-05	0.000531	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—kidney cancer	9.46e-05	0.000528	CcSEcCtD
Montelukast—Pain—Capecitabine—kidney cancer	9.43e-05	0.000526	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—kidney cancer	9.29e-05	0.000518	CcSEcCtD
Montelukast—Diarrhoea—Paclitaxel—kidney cancer	9.2e-05	0.000513	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—kidney cancer	9.04e-05	0.000505	CcSEcCtD
Montelukast—Gastrointestinal pain—Capecitabine—kidney cancer	9.02e-05	0.000503	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—kidney cancer	9.02e-05	0.000503	CcSEcCtD
Montelukast—Dizziness—Paclitaxel—kidney cancer	8.89e-05	0.000496	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—kidney cancer	8.77e-05	0.000489	CcSEcCtD
Montelukast—Urticaria—Capecitabine—kidney cancer	8.76e-05	0.000489	CcSEcCtD
Montelukast—Abdominal pain—Capecitabine—kidney cancer	8.72e-05	0.000487	CcSEcCtD
Montelukast—Body temperature increased—Capecitabine—kidney cancer	8.72e-05	0.000487	CcSEcCtD
Montelukast—Vomiting—Paclitaxel—kidney cancer	8.55e-05	0.000477	CcSEcCtD
Montelukast—Rash—Paclitaxel—kidney cancer	8.47e-05	0.000473	CcSEcCtD
Montelukast—Dermatitis—Paclitaxel—kidney cancer	8.47e-05	0.000473	CcSEcCtD
Montelukast—Headache—Paclitaxel—kidney cancer	8.42e-05	0.00047	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—kidney cancer	8.38e-05	0.000467	CcSEcCtD
Montelukast—Hypersensitivity—Capecitabine—kidney cancer	8.13e-05	0.000454	CcSEcCtD
Montelukast—Agitation—Doxorubicin—kidney cancer	8.01e-05	0.000447	CcSEcCtD
Montelukast—Nausea—Paclitaxel—kidney cancer	7.98e-05	0.000446	CcSEcCtD
Montelukast—Asthenia—Capecitabine—kidney cancer	7.91e-05	0.000442	CcSEcCtD
Montelukast—Pruritus—Capecitabine—kidney cancer	7.8e-05	0.000436	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—kidney cancer	7.7e-05	0.00043	CcSEcCtD
Montelukast—Cough—Doxorubicin—kidney cancer	7.6e-05	0.000424	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—kidney cancer	7.55e-05	0.000421	CcSEcCtD
Montelukast—Diarrhoea—Capecitabine—kidney cancer	7.55e-05	0.000421	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—kidney cancer	7.42e-05	0.000414	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—kidney cancer	7.42e-05	0.000414	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—kidney cancer	7.39e-05	0.000413	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.37e-05	0.000411	CcSEcCtD
Montelukast—Dizziness—Capecitabine—kidney cancer	7.29e-05	0.000407	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—kidney cancer	7.11e-05	0.000397	CcSEcCtD
Montelukast—Oedema—Doxorubicin—kidney cancer	7.11e-05	0.000397	CcSEcCtD
Montelukast—Infection—Doxorubicin—kidney cancer	7.06e-05	0.000394	CcSEcCtD
Montelukast—Vomiting—Capecitabine—kidney cancer	7.01e-05	0.000391	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—kidney cancer	6.97e-05	0.000389	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—kidney cancer	6.96e-05	0.000389	CcSEcCtD
Montelukast—Rash—Capecitabine—kidney cancer	6.95e-05	0.000388	CcSEcCtD
Montelukast—Dermatitis—Capecitabine—kidney cancer	6.95e-05	0.000388	CcSEcCtD
Montelukast—Headache—Capecitabine—kidney cancer	6.91e-05	0.000386	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—kidney cancer	6.91e-05	0.000385	CcSEcCtD
Montelukast—Nausea—Capecitabine—kidney cancer	6.55e-05	0.000366	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.48e-05	0.000362	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—kidney cancer	6.43e-05	0.000359	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—kidney cancer	6.38e-05	0.000356	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—kidney cancer	6.32e-05	0.000353	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—kidney cancer	6.26e-05	0.000349	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.14e-05	0.000343	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—kidney cancer	6.13e-05	0.000342	CcSEcCtD
Montelukast—Pain—Doxorubicin—kidney cancer	6.08e-05	0.000339	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—kidney cancer	5.81e-05	0.000324	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—kidney cancer	5.65e-05	0.000315	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—kidney cancer	5.62e-05	0.000314	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—kidney cancer	5.62e-05	0.000314	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—kidney cancer	5.24e-05	0.000292	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—kidney cancer	5.1e-05	0.000285	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—kidney cancer	5.03e-05	0.000281	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—kidney cancer	4.86e-05	0.000272	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—kidney cancer	4.7e-05	0.000262	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—kidney cancer	4.52e-05	0.000252	CcSEcCtD
Montelukast—Rash—Doxorubicin—kidney cancer	4.48e-05	0.00025	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—kidney cancer	4.48e-05	0.00025	CcSEcCtD
Montelukast—Headache—Doxorubicin—kidney cancer	4.45e-05	0.000249	CcSEcCtD
Montelukast—Nausea—Doxorubicin—kidney cancer	4.22e-05	0.000236	CcSEcCtD
Montelukast—CYP2C8—Metabolism—ACY1—kidney cancer	3e-05	0.000859	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—FH—kidney cancer	2.99e-05	0.000857	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APRT—kidney cancer	2.99e-05	0.000857	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—SLC5A5—kidney cancer	2.97e-05	0.000849	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—GSTM1—kidney cancer	2.93e-05	0.000838	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.93e-05	0.000837	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	2.89e-05	0.000827	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—SLC2A1—kidney cancer	2.87e-05	0.00082	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.84e-05	0.000813	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—POMC—kidney cancer	2.84e-05	0.000812	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APRT—kidney cancer	2.83e-05	0.00081	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—FH—kidney cancer	2.83e-05	0.00081	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPC3—kidney cancer	2.82e-05	0.000805	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.78e-05	0.000796	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.78e-05	0.000795	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.74e-05	0.000784	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CA2—kidney cancer	2.74e-05	0.000783	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALAD—kidney cancer	2.67e-05	0.000764	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPC3—kidney cancer	2.66e-05	0.000762	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ST3GAL2—kidney cancer	2.61e-05	0.000745	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CA2—kidney cancer	2.59e-05	0.000741	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.57e-05	0.000735	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.56e-05	0.000732	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PDHB—kidney cancer	2.55e-05	0.00073	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALDH1A1—kidney cancer	2.55e-05	0.000728	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—POMC—kidney cancer	2.54e-05	0.000728	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.54e-05	0.000727	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALAD—kidney cancer	2.52e-05	0.000722	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF2—kidney cancer	2.51e-05	0.000718	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN2B—kidney cancer	2.5e-05	0.000715	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ST3GAL2—kidney cancer	2.46e-05	0.000705	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ACY1—kidney cancer	2.44e-05	0.000699	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC5A3—kidney cancer	2.44e-05	0.000698	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PGK1—kidney cancer	2.44e-05	0.000698	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1R—kidney cancer	2.43e-05	0.000694	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.43e-05	0.000694	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALDH1A1—kidney cancer	2.41e-05	0.000689	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CCBL1—kidney cancer	2.4e-05	0.000686	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—LDHB—kidney cancer	2.39e-05	0.000685	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTP1—kidney cancer	2.39e-05	0.000684	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—RAF1—kidney cancer	2.34e-05	0.000669	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—IL2—kidney cancer	2.31e-05	0.000661	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PGK1—kidney cancer	2.31e-05	0.00066	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC5A3—kidney cancer	2.31e-05	0.00066	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ABCB1—kidney cancer	2.26e-05	0.000648	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—LDHB—kidney cancer	2.26e-05	0.000648	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTM1—kidney cancer	2.2e-05	0.000629	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.17e-05	0.000621	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.1e-05	0.000601	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL2—kidney cancer	2.1e-05	0.0006	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP1A1—kidney cancer	2.08e-05	0.000596	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.08e-05	0.000596	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.08e-05	0.000595	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPAT—kidney cancer	2.08e-05	0.000595	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PDHB—kidney cancer	2.08e-05	0.000594	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CA9—kidney cancer	2.08e-05	0.000594	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.07e-05	0.000593	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—POMC—kidney cancer	2.07e-05	0.000592	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.05e-05	0.000588	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.03e-05	0.000582	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.03e-05	0.00058	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HIF1A—kidney cancer	2e-05	0.000572	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TSC2—kidney cancer	1.99e-05	0.00057	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CA9—kidney cancer	1.96e-05	0.000561	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CCBL1—kidney cancer	1.95e-05	0.000559	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APRT—kidney cancer	1.93e-05	0.000553	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—FH—kidney cancer	1.93e-05	0.000553	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.93e-05	0.000553	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KDR—kidney cancer	1.91e-05	0.000547	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.91e-05	0.000545	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.89e-05	0.000541	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.83e-05	0.000524	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPC3—kidney cancer	1.82e-05	0.00052	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.81e-05	0.000517	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CA2—kidney cancer	1.77e-05	0.000506	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.77e-05	0.000505	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CRABP1—kidney cancer	1.77e-05	0.000505	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KIT—kidney cancer	1.76e-05	0.000504	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APC—kidney cancer	1.76e-05	0.000504	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALAD—kidney cancer	1.72e-05	0.000493	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.71e-05	0.00049	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.69e-05	0.000484	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPAT—kidney cancer	1.69e-05	0.000484	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—MAPK3—kidney cancer	1.69e-05	0.000482	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.68e-05	0.000481	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—POMC—kidney cancer	1.68e-05	0.000479	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.67e-05	0.000478	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CRABP1—kidney cancer	1.67e-05	0.000477	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.66e-05	0.000473	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BRAF—kidney cancer	1.66e-05	0.000473	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.64e-05	0.00047	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ITPR2—kidney cancer	1.64e-05	0.000469	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ACY1—kidney cancer	1.61e-05	0.000461	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—MAPK1—kidney cancer	1.6e-05	0.000459	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PGK1—kidney cancer	1.58e-05	0.000451	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.58e-05	0.000451	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—FH—kidney cancer	1.57e-05	0.00045	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APRT—kidney cancer	1.57e-05	0.00045	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—POMC—kidney cancer	1.55e-05	0.000444	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ITPR2—kidney cancer	1.55e-05	0.000444	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LDHB—kidney cancer	1.55e-05	0.000442	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.54e-05	0.00044	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CA—kidney cancer	1.53e-05	0.000439	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—KRAS—kidney cancer	1.52e-05	0.000434	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.51e-05	0.000433	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ACHE—kidney cancer	1.5e-05	0.000428	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTT1—kidney cancer	1.5e-05	0.000428	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPC3—kidney cancer	1.48e-05	0.000423	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CA2—kidney cancer	1.44e-05	0.000412	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SCARB1—kidney cancer	1.42e-05	0.000405	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTT1—kidney cancer	1.42e-05	0.000405	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ACHE—kidney cancer	1.42e-05	0.000405	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALAD—kidney cancer	1.4e-05	0.000401	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CA—kidney cancer	1.39e-05	0.000398	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RAF1—kidney cancer	1.38e-05	0.000395	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RELA—kidney cancer	1.38e-05	0.000394	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PSMD7—kidney cancer	1.38e-05	0.000393	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PDHB—kidney cancer	1.37e-05	0.000392	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.37e-05	0.000392	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ERBB2—kidney cancer	1.37e-05	0.000391	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—POMC—kidney cancer	1.37e-05	0.000391	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MTOR—kidney cancer	1.35e-05	0.000386	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CA9—kidney cancer	1.34e-05	0.000384	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SCARB1—kidney cancer	1.34e-05	0.000383	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.34e-05	0.000383	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS1—kidney cancer	1.33e-05	0.000379	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.31e-05	0.000375	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—BCHE—kidney cancer	1.3e-05	0.000373	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PSMD7—kidney cancer	1.3e-05	0.000372	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CCBL1—kidney cancer	1.29e-05	0.000368	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC5A5—kidney cancer	1.29e-05	0.000368	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PGK1—kidney cancer	1.28e-05	0.000367	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.28e-05	0.000367	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1B—kidney cancer	1.27e-05	0.000362	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LDHB—kidney cancer	1.26e-05	0.00036	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC2A1—kidney cancer	1.24e-05	0.000356	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—kidney cancer	1.24e-05	0.000354	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—kidney cancer	1.24e-05	0.000354	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—BCHE—kidney cancer	1.23e-05	0.000353	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC5A5—kidney cancer	1.22e-05	0.000348	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCND1—kidney cancer	1.21e-05	0.000346	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.21e-05	0.000345	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JUN—kidney cancer	1.21e-05	0.000345	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CTNNB1—kidney cancer	1.2e-05	0.000342	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC2A1—kidney cancer	1.18e-05	0.000336	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—kidney cancer	1.17e-05	0.000334	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000326	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.12e-05	0.000319	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPAT—kidney cancer	1.12e-05	0.000319	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CA9—kidney cancer	1.09e-05	0.000312	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—kidney cancer	1.08e-05	0.000309	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.07e-05	0.000305	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000303	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—kidney cancer	1.05e-05	0.000301	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.05e-05	0.000301	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—FH—kidney cancer	1.04e-05	0.000297	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APRT—kidney cancer	1.04e-05	0.000297	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTP1—kidney cancer	1.04e-05	0.000297	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK3—kidney cancer	9.96e-06	0.000285	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—kidney cancer	9.82e-06	0.000281	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTP1—kidney cancer	9.81e-06	0.000281	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.77e-06	0.000279	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPC3—kidney cancer	9.76e-06	0.000279	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—kidney cancer	9.69e-06	0.000277	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTT1—kidney cancer	9.67e-06	0.000276	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ACHE—kidney cancer	9.67e-06	0.000276	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—kidney cancer	9.53e-06	0.000273	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CA2—kidney cancer	9.5e-06	0.000272	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK1—kidney cancer	9.48e-06	0.000271	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCB1—kidney cancer	9.28e-06	0.000266	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CRABP1—kidney cancer	9.28e-06	0.000265	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALAD—kidney cancer	9.25e-06	0.000265	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SCARB1—kidney cancer	9.15e-06	0.000262	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS1—kidney cancer	9.06e-06	0.000259	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP1A1—kidney cancer	9.04e-06	0.000258	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.03e-06	0.000258	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTM1—kidney cancer	9.01e-06	0.000258	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KRAS—kidney cancer	8.95e-06	0.000256	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PSMD7—kidney cancer	8.88e-06	0.000254	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.83e-06	0.000253	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ITPR2—kidney cancer	8.63e-06	0.000247	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP1A1—kidney cancer	8.54e-06	0.000244	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.46e-06	0.000242	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PGK1—kidney cancer	8.46e-06	0.000242	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—BCHE—kidney cancer	8.42e-06	0.000241	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC5A5—kidney cancer	8.32e-06	0.000238	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LDHB—kidney cancer	8.3e-06	0.000237	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—kidney cancer	8.23e-06	0.000235	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC2A1—kidney cancer	8.03e-06	0.00023	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—kidney cancer	7.96e-06	0.000228	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.95e-06	0.000227	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTT1—kidney cancer	7.87e-06	0.000225	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ACHE—kidney cancer	7.87e-06	0.000225	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.79e-06	0.000223	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—kidney cancer	7.62e-06	0.000218	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SCARB1—kidney cancer	7.45e-06	0.000213	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.42e-06	0.000212	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS1—kidney cancer	7.37e-06	0.000211	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PSMD7—kidney cancer	7.23e-06	0.000207	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CA9—kidney cancer	7.2e-06	0.000206	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—BCHE—kidney cancer	6.85e-06	0.000196	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.8e-06	0.000194	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.77e-06	0.000194	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—POMC—kidney cancer	6.74e-06	0.000193	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTP1—kidney cancer	6.7e-06	0.000192	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.54e-06	0.000187	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—POMC—kidney cancer	6.37e-06	0.000182	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.34e-06	0.000181	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—kidney cancer	6.34e-06	0.000181	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—kidney cancer	6.16e-06	0.000176	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CRABP1—kidney cancer	6.12e-06	0.000175	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP1A1—kidney cancer	5.84e-06	0.000167	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ITPR2—kidney cancer	5.69e-06	0.000163	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.53e-06	0.000158	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTP1—kidney cancer	5.45e-06	0.000156	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—kidney cancer	5.37e-06	0.000154	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ACHE—kidney cancer	5.19e-06	0.000148	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTT1—kidney cancer	5.19e-06	0.000148	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—kidney cancer	5.16e-06	0.000148	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—kidney cancer	5.08e-06	0.000145	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—kidney cancer	5.01e-06	0.000143	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SCARB1—kidney cancer	4.91e-06	0.00014	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS1—kidney cancer	4.86e-06	0.000139	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.79e-06	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PSMD7—kidney cancer	4.77e-06	0.000136	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.75e-06	0.000136	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—kidney cancer	4.69e-06	0.000134	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—BCHE—kidney cancer	4.52e-06	0.000129	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.46e-06	0.000128	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—kidney cancer	4.43e-06	0.000127	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—POMC—kidney cancer	4.35e-06	0.000124	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.31e-06	0.000123	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.9e-06	0.000112	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTP1—kidney cancer	3.6e-06	0.000103	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—POMC—kidney cancer	3.54e-06	0.000101	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—kidney cancer	3.47e-06	9.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—kidney cancer	3.4e-06	9.74e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—kidney cancer	3.31e-06	9.46e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—kidney cancer	3.3e-06	9.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.13e-06	8.96e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—kidney cancer	3.13e-06	8.94e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—kidney cancer	3.03e-06	8.66e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—kidney cancer	2.82e-06	8.08e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—kidney cancer	2.46e-06	7.05e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—POMC—kidney cancer	2.34e-06	6.68e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.14e-06	6.11e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—kidney cancer	1.86e-06	5.33e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.74e-06	4.97e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—kidney cancer	1.62e-06	4.65e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.15e-06	3.28e-05	CbGpPWpGaD
